OGEN vs IBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

OGEN

47.9
AI Score
VS
OGEN Wins

IBIO

45.7
AI Score

Investment Advisor Scores

OGEN

48score
Recommendation
HOLD

IBIO

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric OGEN IBIO Winner
Revenue 37,653 1.07M IBIO
Net Income -7.91M -7.55M IBIO
Net Margin -21003.1% -702.4% IBIO
Operating Income -8.11M -8.34M OGEN
ROE -121.7% -9.6% IBIO
ROA -100.1% -8.5% IBIO
Total Assets 7.90M 88.65M IBIO
Cash 5.77M 45.44M IBIO
Current Ratio 5.57 9.48 IBIO

Relative Price Performance (Last 90 Days)

OGEN 1M: -19.9% · 3M: -34.3% IBIO 1M: -2.4% · 3M: -46.7%

Current Technical Phase

OGEN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.9%), weak momentum, RSI 32

RSI (14): 31.7 · Price: $0.35

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.3%), weak momentum, RSI 41

RSI (14): 41.3 · Price: $0.76

Fundamentals Snapshot

Metric OGEN IBIO
Market Cap — —
Forward P/E -0.5 -2.5
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.9% -1.0%
Gross Margin — 1.0%
Operating Margin 0.0% -301.4%
EPS -2.43 -0.27
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, OGEN is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.